Publications
New Book Chapter: Microfluidic Platforms for Body-on-a-Chip Systems
Ken-ichiro Kamei coauthors a new book chapter exploring microfluidic platform design, organoids, sensors and the challenges of integrating body-on-a-chip systems.
Ken-ichiro Kamei coauthors a new book chapter exploring microfluidic platform design, organoids, sensors and the challenges of integrating body-on-a-chip systems.
A new Perspective proposes liver development as the engineering blueprint for next-generation liver-on-a-chip systems, connecting stem cells, organoids, microfluidics, and Digital Twins.
A Review that grew out of the Nanobiotechnology Class at NYU Abu Dhabi explores PSMA-targeted quantum dots as complementary optical probes for recurrent prostate cancer imaging.
From the lab · Publication and news [New Publication] Primed human pluripotent stem cell-derived blastocyst-like cell aggregates with partial lineage specification Published 2025-11-12 Our latest paper, “Primed human pluripotent stem cell-derived blastocyst-like cell aggregates with partial lineage specification,” has been published in Regenerative Therapy (Elsevier, 2025) — DOI: 10.1016/j.reth.2025.10.007. We Read more…
From the lab · Publication and news [New Publication] High-Purity Production of Endothelial Cells from Human Pluripotent Stem Cells Published 2025-11-12 Authors: Koki Yoshimoto, Ririka Okaichi, Kei Iida, Shiho Terada, and Ken-ichiro Kamei Our latest paper, “High-Purity Production of Endothelial Cells from Human Pluripotent Stem Cells”, has been published in Read more…
From the lab · Publication and news The 1st MENA Conference on Living Therapeutics: A Resounding Success Published 2025-11-12 Abu Dhabi, November 5–6, 2025 — The inaugural MENA Conference on Living Therapeutics, hosted by New York University Abu Dhabi (NYUAD) and organized by Assoc. Prof. Ken-ichiro Kamei, Assoc. Prof. Jeremy Read more…
Our latest research has been published in Chemical Engineering Journal: Title: Nanoengineered Redox-Responsive Platforms for Dual-Targeted NSCLC Therapy with Tumor-on-a-Chip Epithelial-Mesenchymal Transition Profiling In this work, we present a rationally designed binary hybrid nanoassembly (OL@R NPs) that co-delivers a redox-responsive platinum(IV) prodrug of oxaliplatin and the ferroptosis inducer RSL3. This Read more…
Thrilled to share our latest work in collaboration with Shenyang Pharmaceutical University, now published in the International Journal of Pharmaceutics: Title:Self-amplifying ROS-responsive trinity nanodelivery system for enhanced cancer therapy Highlights: 🧪 This study showcases the power of integrating nanotechnology with advanced in vitro and in vivo models to address ferroptosis Read more…
I am delighted to share that I will deliver a keynote address at the 4th UAE Anatomy & Cellular Biology Conference on 10–11 May 2025, hosted by Dubai Medical University in Dubai, UAE. The meeting gathers leading anatomists, cell biologists, clinicians, and innovators to explore frontier topics ranging from applied Read more…
We are thrilled to share our latest research in collaboration with Shenyang Pharmaceutical University! Our study, led by Dr. Chutong Tian, introduces a self-motivated carrier-free nanoplatform that synergizes photodynamic therapy (PDT) and ferroptosis for targeted anticancer treatment. Title: A self-motivated carrier free nanoplatform for synergistic photodynamic and ferroptosis-based therapy for Read more…